Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Blueweave Consulting & Research Private Limited | PRODUCT CODE: 1134177

Cover Image

PUBLISHER: Blueweave Consulting & Research Private Limited | PRODUCT CODE: 1134177

Global Artificial Cornea and Corneal Implant Market, By Type, By Transplant Type, By Disease Indication, By End-User Trend Analysis, Competitive Market Share & Forecast, 2018-2028

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4450
PDF (Global License)
USD 5550
PDF (Enterprise License)
USD 7850

Add to Cart

Global Artificial Cornea and Corneal Implant Market to Grow at a CAGR of 12% until 2028

The aging population, increased incidence of eye diseases, government initiatives to lessen visual impairment, and the rising prevalence of eye diseases are the main factors driving the Global Artificial Cornea and Corneal Implant Market.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Artificial Cornea and Corneal Implant Market was worth USD 397.5 million in the year 2021. The market is projected to grow at a CAGR of 12%, earning revenues of around USD 863.7 million by the end of 2028. The Global Artificial Cornea and Corneal Implant Market are booming because the willingness of the consumer to spend money on eye care is credited with driving the expansion in the artificial cornea implant market. Additionally, the main driver of the market's growth is the rise in ophthalmic illnesses such as keratoconus, Fuchs dystrophy, and viral keratitis. In addition, rising healthcare costs for eye treatment in emerging nations are fueling the expansion of the artificial cornea implant market globally. Additionally, the market can expand as a result of factors including the rise in surgical procedures and the demand for innovative treatment methods. The development of the global artificial cornea implant market, however, is threatened by the high cost of cornea implant surgeries. Additionally, complications from corneal procedures hinder the widespread use of corneal implants.

Eye Diseases Are Increasingly Common

The global population of persons suffering from serious eye problems is growing, and vision loss is becoming a major public health concern. The rising prevalence of chronic diseases such as diabetes and hypertension, as well as the aging population, have all contributed to an increase in the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind or low-vision people is likewise predicted to climb dramatically. According to the Royal National Institute of Blind People (RNIB), over 2 million people in the United Kingdom suffered from sight loss in 2013, with that number expected to climb to 4.1 million by 2050. The globe now, there are 146 million cases of trachoma, of which 10 million have trichiasis and need surgery to prevent corneal blindness, and 4.9 million have trachomatous corneal scarring that has caused them to become completely blind. This results in offering lucrative opportunities for the Global Artificial Cornea and Corneal Implant Market during the forecast period (2022-2028).

Lack of Corneal Donors

There is an urgent need for corneal donors because around 10 million people worldwide require corneal transplants. Because of a significant lack of donor corneas, there is a more than six-month waiting list for corneal transplants among those with corneal blindness in densely populated countries like India. About 1 million Americans and 6.8 million persons in the country, respectively, suffer visual problems in both eyes as a result of corneal diseases. By the end of 2020, 10.6 million cases of unilateral corneal blindness were expected to occur in India. In 2019, there were about 120,000 cases of corneal blindness. Although the country needs roughly 250,000 corneas annually, only about 25,000 are donated. Given the significant burden of corneal blindness and the scarcity of corneal donors, manufacturers of corneal implants should have significant development potential.

Challenges: Insufficient Ophthalmologists

Ophthalmologists are still in great demand, although their numbers have not grown as quickly as the global population. This is especially clear in emerging nations. In India, for instance, there is one ophthalmologist for every 107,000 people, compared to one for every 15,800 in the US. While some locations (mostly urban centers) have ratios of 1:9,000, other others have ratios as low as 1:608,000. The average number of ophthalmologists per million inhabitants varies depending on the country's level of economic development, from nine per million on average in low-income nations to 79 per million on average in high-income nations. There were more than 100 ophthalmologists per million persons in just 18 countries (Source: World Bank).

Segmental Coverage

Global Artificial Cornea and Corneal Implant Market - By End-User

Based on end-user, the Global Artificial Cornea and Corneal Implant Market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others. During the projected period, the category for specialty clinics and ASCs is anticipated to have the greatest CAGR. The decline in in-patient surgeries and the rise in demand for minimally invasive procedures are both factors contributing to this segment's growth. Concerns about hospital-acquired infections and patient preferences for effective treatment are further fostering the expansion of this market.

Impact of COVID-19 on Global Artificial Cornea and Corneal Implant Market

Due to lockdowns and other restrictions put in place to stop the COVID-19 epidemic, there has been a considerable decrease in the number of patient visits to clinics in the first and second quarters of 2020. As a result, fewer elective eye procedures were performed each week in hospitals and clinics during that time. The number of elective procedures has decreased from 200 surgeries per week to just ten surgeries per week, according to the Ophthalmology Times story. Additionally, the frequency of patient appointments to examination centers has been canceled by 15% in nations like the US. The coronavirus disease (COVID-19) pandemic caused a large loss in patient volume for ophthalmology, according to the same publication. According to estimates, the number of patients seeking glaucoma treatment decreased by 88% and those seeking cataract surgery by 97%. Government programs assisted numerous practices during this time, including Paycheck Protection Program loans, which enabled the ophthalmology sector to successfully continue operations

Competitive Landscape

The leading market players in the Global Artificial Cornea and Corneal Implant Market are AJL Ophthalmic, CorneaGen Inc, Addition Technology Inc, LinkoCare Life Science AB, Presbia Plc, Mediphacos, Aurolab, Cornea Biosciences, Dioptex GmbH, EyeYon Medical, Massachusetts Eye and Ear, Florida Lions Eye Bank, and other prominent players.

The Global Artificial Cornea and Corneal Implant Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Artificial Cornea and Corneal Implant Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Artificial Cornea and Corneal Implant Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC22331

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Transplant Type Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Research
  • 2.2. Quantitative Research
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global Artificial Cornea and Corneal Implant Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Advancement/Recent Development
  • 4.4. Regulatory Framework
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global Artificial Cornea and Corneal Implant Market Overview

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
      • 5.2.1.1. Human Cornea
      • 5.2.1.2. Artificial Cornea
    • 5.2.2. By Transplant Type
      • 5.2.2.1. Penetrating Keratoplasty
      • 5.2.2.2. Endothelial Keratoplasty
    • 5.2.3. By Disease Indication
      • 5.2.3.1. Fuch's Dystrophy
      • 5.2.3.2. Fungal Keratitis
      • 5.2.3.3. Keratoconus
      • 5.2.3.4. Others
    • 5.2.4. By End-User
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Specialty Clinics
      • 5.2.4.3. Ambulatory Surgical Centers
      • 5.2.4.4. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. The Asia Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. The Middle East and Africa

6. North America Artificial Cornea and Corneal Implant Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Transplant Type
    • 6.2.3. By Disease Indication
    • 6.2.4. By End-User
    • 6.2.5. By Country
      • 6.2.5.1. United Type
      • 6.2.5.2. Canada

7. Europe Artificial Cornea and Corneal Implant Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Transplant Type
    • 7.2.3. By Disease Indication
    • 7.2.4. By End-User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. United Kingdom
      • 7.2.5.3. Italy
      • 7.2.5.4. France
      • 7.2.5.5. Spain
      • 7.2.5.6. Rest of Europe

8. The Asia Pacific Artificial Cornea and Corneal Implant Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Transplant Type
    • 8.2.3. By Disease Indication
    • 8.2.4. By End-User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Artificial Cornea and Corneal Implant Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Transplant Type
    • 9.2.3. By Disease Indication
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Rest of Latin America

10. The Middle East & Africa Artificial Cornea and Corneal Implant Market

  • 10.1. Market Size & Forecast by Value, 2018-2028
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Transplant Type
    • 10.2.3. By Disease Indication
    • 10.2.4. By End-User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of the Middle East & Africa

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis, 2021
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Covid-19 on Global Artificial Cornea and Corneal Implant Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

  • 13.1. AJL Ophthalmic
  • 13.2. CorneaGen Inc
  • 13.3. Addition Technology Inc
  • 13.4. LinkoCare Life Science AB
  • 13.5. Presbia Plc
  • 13.6. Mediphacos
  • 13.7. Aurolab
  • 13.8. Cornea Biosciences
  • 13.9. Dioptex GmbH
  • 13.10. EyeYon Medical
  • 13.11. Massachusetts Eye and Ear
  • 13.12. Florida Lions Eye Bank
  • 13.13. Other Prominent Players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

Product Code: BWC22331

List of Figures

  • Figure 1: Global Artificial Cornea and Corneal Implant Market Segmentation
  • Figure 2: Global Artificial Cornea and Corneal Implant Market Industry Value Chain Analysis
  • Figure 3: Global Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 4: Global Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 5: Global Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 6: Global Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 7: Global Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 8: Global Artificial Cornea and Corneal Implant Market Share (%), By Region, By Value, 2018-2028
  • Figure 9: North America Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 10: North America Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 11: North America Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 12: North America Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 13: North America Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 14: North America Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 15: Europe Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 16: Europe Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 17: Europe Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 18: Europe Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 19: Europe Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 20: Europe Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 21: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 22: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 23: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 24: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 25: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 26: The Asia-Pacific Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 27: Latin America Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 28: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 29: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 30: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 31: Latin America Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 32: Latin America Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 33: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Value (USD Million), 2018-2028
  • Figure 34: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Type, By Value, 2018-2028
  • Figure 35: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Transplant Type, By Value, 2018-2028
  • Figure 36: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Disease Indication, By Value, 2018-2028
  • Figure 37: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By End-User, By Value, 2018-2028
  • Figure 38: The Middle East & Africa Artificial Cornea and Corneal Implant Market Share (%), By Country, By Value, 2018-2028
  • Figure 39: Global Artificial Cornea and Corneal Implant Market Share Analysis, 2021

List of Tables

  • Table 1: Global Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 2: Global Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 3: Global Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 4: Global Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 5: Global Artificial Cornea and Corneal Implant Market Size. By Region, By Value (USD Million), 2018-2028
  • Table 6: North America Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 7: North America Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 8: North America Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 9: North America Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 10: North America Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 11: Europe Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 12: Europe Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), By Value 2018-2028
  • Table 13: Europe Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), By Value 2018-2028
  • Table 14: Europe Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), By Value 2018-2028
  • Table 15: 40 Europe Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 16: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 17: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Type, By Value 2018-2028
  • Table 18: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Transplant Type, By Value 2018-2028
  • Table 19: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Disease Indication, By Value 2018-2028
  • Table 20: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By End-User, By Value 2018-2028
  • Table 21: The Asia-Pacific Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 22: Latin America Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 23: Latin America Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 24: Latin America Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 25: Latin America Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 26: Latin America Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 27: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 28: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Transplant Type, By Value (USD Million), 2018-2028
  • Table 29: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By Disease Indication, By Value (USD Million), 2018-2028
  • Table 30: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 31: The Middle East & Africa Artificial Cornea and Corneal Implant Market Size (USD Million), By Country, By Value 2018-2028
  • Table 32: List of Key Players and Their Offerings
  • Table 33: Competitive Benchmarking, by Operating Parameters
  • Table 34 AJL Ophthalmic Company Overview
  • Table 35 AJL Ophthalmic Financial Overview
  • Table 36 CorneaGen Inc Company Overview
  • Table 37 CorneaGen Inc Financial Overview
  • Table 38 Addition Technology Inc Company Overview
  • Table 39 Addition Technology Inc Financial Overview
  • Table 40 LinkoCare Life Science AB Company Overview
  • Table 41 LinkoCare Life Science AB Financial Overview
  • Table 42 Presbia Plc Company Overview
  • Table 43 Presbia Plc Financial Overview
  • Table 44 Mediphacos Company Overview
  • Table 45 Mediphacos Financial Overview
  • Table 46 Aurolab Company Overview
  • Table 47 Aurolab Financial Overview
  • Table 48 Cornea Biosciences Company Overview
  • Table 49 Cornea Biosciences Financial Overview
  • Table 50 Dioptex GmbH Company Overview
  • Table 51 Dioptex GmbH Financial Overview
  • Table 52 EyeYon Medical Company Overview
  • Table 53 EyeYon Medical Financial Overview
  • Table 54 Massachusetts Eye and Ear Company Overview
  • Table 55 Massachusetts Eye and Ear Financial Overview
  • Table 56 Florida Lions Eye Bank Company Overview
  • Table 57 Florida Lions Eye Bank Financial Overview
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!